PATHWAY PROFILING ANTIBODIES & REAGENTS
     
Products
Press Release
1. IMGENEX and Genzyme Molecular Oncology form Alliance.
2. IMGENEX Corp. Acquires Exclusive North American Distribution Rights to sale, Tissue and Tumor Arrays Used in High-Throughput Studies of functional Genomics.
3. IMGENEX Now Offers Antibodies Against SARS
"We believe IMGENEX antibodies will greatly facilitate research on SARS infection," said Jason Stampfl, director of Antibody Production at IMGENEX.
4. RNAi Roundup: Waltham Conference
IMGENEX presentation at RNAi meeting, Waltham, MA.

About IMGENEX
IMGENEX develops and commercializes novel reagents for the scientific study of human biology and disease and for the production of new diagnostic assays and potential therapies of such diseases. These novel reagents include antibodies, gene and protein expression systems, and arrays of various cells and tissues for use in studies of functional genomics. Areas of biological interest at Imgenex include cancer, apoptosis (programmed cell death), molecular signaling pathways, cellular aging, and metabolic and infectious diseases.

Press Contacts:
IMGENEX Corporation
Sujay Singh, Ph.D.
(858)642-0978, ext. 222
Fax: (858)642-0937
Toll free: 888/723-GENE (4363)
ssingh@imgenex.com

Products

Services

Resources

Purchasing

Company

     

© IMGENEX Corporation
Toll Free: 1-888-723-4363
Phone: 1-858-642-0978
Fax: 1-858-642-0937 Email: info@imgenex.com

All products are For Research Use Only, unless indicated otherwise. Not for use in diagnostic or therapeutic procedures.